This Journal feature begins with a case vignette highlighting a common clinical problem. Evidence supporting various strategies is then presented, followed by a review of formal guidelines, when they ...

A patient develops pericarditis 19 days after testing positive test for COVID-19. The authors describe how to recognize, diagnose, and treat this condition. This is the fourth installment of our ...

Myopericarditis is a primarily pericardial inflammatory syndrome occurring when clinical diagnostic criteria for pericarditis are satisfied and concurrent mild myocardial involvement is documented by ...

Colchicine is effective for the treatment of recurrent pericarditis. However, conclusive data are lacking regarding the use of colchicine during a first attack of acute pericarditis and in the ...

Although allogeneic hematopoietic stem cell transplantation (HSCT) can be curative for various hematological disorders, it continues to be associated with a significant incidence of treatment-related ...

The US Food and Drug Administration (FDA) has approved rilonacept (Arcalyst) to treat recurrent pericarditis and reduce the risk for recurrence in adults and children 12 years and older. Approval of ...

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window A 44-year-old ...

Kiniksa Pharmaceuticals International, plc (Nasdaq: KNSA) (Kiniksa), a biopharmaceutical company developing and commercializing novel therapies for diseases with unmet need, with a focus on ...

Pericarditis often causes sudden chest pain that is sharp or stabbing. It can be mistaken for a heart attack. It also can mimic a lung condition. Carly Pearce vividly remembers the intense chest pain.

Acute pericarditis is inflammation of the membrane surrounding the heart that develops suddenly and causes sharp chest pain. The cause is usually a viral or bacterial infection. The condition is ...